KRRO · Korro Bio, Inc.
$12.25
-0.03 (-0.24%)
At close · Jul 17
Market Cap
$176.68M
Shares
14,422,571
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Ram Aiyar | CEO | $3,119,591 |
| Kemi Olugemo | Former Chief Medical Officer | $2,341,530 |
| Vineet Agarwal | CFO | $1,719,273 |
| Jeffrey Cerio | General Counsel | $1,578,451 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Kemi Olugemo | Former Chief Medical Officer | $2,730,512 |
| Jeffrey Cerio | General Counsel | $1,546,330 |
| Ram Aiyar | CEO | $939,075 |
| Vineet Agarwal | CFO | $617,550 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| David L. Lucchino | CEO | $3,878,265 |
| Ram Aiyar | CEO | $2,858,230 |
| Steven Colletti | Chief Scientific Officer | $1,647,368 |
| Christopher R. Loose | Chief Scientific Officer | $1,580,474 |
| Vineet Agarwal | CFO | $1,322,891 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| David L. Lucchino | CEO | $3,159,278 |
| Christopher R. Loose | Chief Scientific Officer | $1,518,812 |
| Ram Aiyar | CEO | $1,196,545 |
| Vineet Agarwal | CFO | $629,008 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| David L. Lucchino | CEO | $5,821,532 |
| Quentin McCubbin | Chief Manufacturing Officer | $3,303,416 |
| Carl P. LeBel | Chief Development Officer | $2,750,743 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| David L. Lucchino | CEO | $5,217,638 |
| Peter P. Pfreundschuh | CFO | $4,351,036 |
| Wendy S. Arnold | Chief People Officer | $2,773,413 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| David L. Lucchino | CEO | $7,364,604 |
| Christopher R. Loose | Chief Scientific Officer | $2,894,515 |
| Carl LeBel | Chief Development Officer | $2,217,219 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| David L. Lucchino | CEO | $743,700 |
| Christopher R. Loose | Chief Scientific Officer | $578,134 |
| Carl LeBel | Chief Development Officer | $477,721 |